Dolby Laboratories (DLB) FY2021 results: revenue $1.3 billion, up 10.3% on the year
Dolby Laboratories, Inc. (DLB) reported revenue of $1.3 billion for fiscal 2021, the year ended 24 September 2021, up 10.3% on the year before. Net income was $310 million, up 34.1%, and diluted earnings per share $2.97. The figures are the company's own, from the 10-K it filed with the SEC on 17 November 2021.
Revenue
$1.3 billion
+10.3% on the year
FY2014FY2021
Operating margin
26.9%
18.8% a year earlier
FY2014FY2021
Net income
$310 million
+34.1% on the year
FY2014FY2021
Diluted EPS
$2.97
+32.0% on the year
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Revenue
1,281
1,162
1,242
+10.3%
Cost of revenue
130
146
161
-11.2%
Gross profit
1,151
1,015
1,081
+13.4%
Gross margin
89.9%
87.4%
87.0%
Research and development
254
239
238
+6.1%
Operating income
344
219
257
+57.4%
Operating margin
26.9%
18.8%
20.7%
Interest expense
0.5
0.2
0.2
+157.5%
Pre-tax income
355
240
282
+47.9%
Income tax
36.7
8.1
26.8
+353.2%
Effective tax rate
10.3%
3.4%
9.5%
Net income
310
231
255
+34.1%
Net margin
24.2%
19.9%
20.5%
Diluted EPS
$2.97
$2.25
$2.44
+32.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
448
344
328
+30.2%
Capital expenditure
54.5
66.3
96.3
-17.9%
Free cash flow
393
278
231
+41.7%
Free cash flow margin
30.7%
23.9%
18.6%
Cash from investing
-44.9
134
-56.2
Cash from financing
-253
-208
-385
Depreciation and amortisation
95.9
90.9
85.1
+5.5%
Share-based compensation
99.7
86.6
76.6
+15.1%
Buybacks
246
174
341
+41.5%
Dividends paid
89.2
88.6
77.5
+0.7%
Dividend per share
$0.91
$0.88
$0.79
+3.4%
Diluted shares, weighted
105m
103m
105m
+1.6%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
2,598
2,433
2,307
+6.8%
Non-controlling interest
6.3
5.8
5.7
+8.5%
Debt
0.0
0.0
0.0
Operating lease liabilities
56.7
65.3
0.0
-13.2%
Other liabilities
445
414
509
+7.5%
Total liabilities and equity
3,106
2,917
2,822
+6.5%
Fixed assets
534
542
537
-1.4%
Goodwill
341
337
335
+1.1%
Intangible assets
123
152
181
-19.4%
Investments
102
99.1
299
+2.6%
Cash and equivalents
1,225
1,072
797
+14.3%
Receivables
233
180
189
+29.0%
Inventory
11.0
25.6
32.3
-57.1%
Other assets
537
509
451
+5.5%
Total assets
3,106
2,917
2,822
+6.5%
10-K for the year ended 24 September 2021, filed 17 November 2021: the filing.